Caption Management, LLC Apellis Pharmaceuticals, Inc. Call Options Transaction History

Caption Management, LLC

$5.74 Billion
Q3 2024

Call Options

20 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Nov 14, 2024	SELL	$28.84 - $41.15 $12 Million - $17.1 Million	-414,700 Reduced 41.28%	590,000 $17 Million
Q2 2024 Aug 14, 2024	BUY	$38.07 - $59.71 $36 Million - $56.4 Million	944,700 Added 1574.5%	1,004,700 $38.5 Million
Q1 2024 May 15, 2024	SELL	$55.39 - $72.47 $15.3 Million - $20 Million	-276,400 Reduced 82.16%	60,000 $3.53 Million
Q4 2023 Feb 14, 2024	SELL	$37.14 - $64.82 $9.31 Million - $16.3 Million	-250,800 Reduced 42.71%	336,400 $20.1 Million
Q3 2023 Nov 14, 2023	BUY	$23.65 - $89.22 $9.97 Million - $37.6 Million	421,700 Added 254.8%	587,200 $22.3 Million
Q2 2023 Aug 14, 2023	SELL	$76.68 - $93.31 $29.5 Million - $35.9 Million	-385,000 Reduced 69.94%	165,500 $15.1 Million
Q1 2023 May 15, 2023	BUY	$46.59 - $66.96 $24 Million - $34.5 Million	515,500 Added 1472.86%	550,500 $36.3 Million
Q4 2022 Feb 14, 2023	SELL	$43.24 - $61.04 $1.3 Million - $1.83 Million	-30,000 Reduced 46.15%	35,000 $1.81 Million
Q3 2022 Nov 14, 2022	BUY	$44.76 - $69.66 $2.91 Million - $4.53 Million	65,000 New	65,000 $4.44 Million
Q2 2022 Aug 15, 2022	SELL	$35.07 - $59.21 $2.29 Million - $3.87 Million	-65,300 Closed	0 $0
Q1 2022 May 13, 2022	BUY	$35.46 - $54.12 $1.25 Million - $1.91 Million	35,300 Added 117.67%	65,300 $3.32 Million
Q4 2021 Feb 11, 2022	SELL	$30.74 - $49.16 $15.1 Million - $24.1 Million	-490,900 Reduced 94.24%	30,000 $1.42 Million
Q3 2021 Nov 12, 2021	BUY	$31.4 - $69.84 $10.5 Million - $23.5 Million	335,900 Added 181.57%	520,900 $17.2 Million
Q2 2021 Aug 16, 2021	BUY	$40.9 - $64.9 $5.64 Million - $8.96 Million	138,000 Added 293.62%	185,000 $11.7 Million
Q1 2021 May 17, 2021	BUY	$40.8 - $57.39 $1.92 Million - $2.7 Million	47,000 New	47,000 $2.02 Million
Q4 2020 Feb 16, 2021	SELL	$30.79 - $57.2 $923,700 - $1.72 Million	-30,000 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$25.89 - $33.65 $776,700 - $1.01 Million	30,000 New	30,000 $904,000
Q2 2020 Aug 14, 2020	SELL	$24.8 - $38.49 $133,920 - $207,846	-5,400 Closed	0 $0
Q1 2020 May 15, 2020	SELL	$17.91 - $44.33 $1.79 Million - $4.43 Million	-100,000 Reduced 94.88%	5,400 $144,000
Q4 2019 Feb 13, 2020	BUY	$22.1 - $30.8 $2.33 Million - $3.25 Million	105,400 New	105,400 $3.23 Million

Others Institutions Holding APLS

# of Institutions

308

Shares Held

115M

Call Options Held

3.85M

Put Options Held

1.09M

Wellington Management Group LLP Boston, MA

15.6M
Shares

$516 Million
0.08% of portfolio
Eco R1 Capital, LLC San Francisco, CA

11.9M
Shares

$394 Million
14.88% of portfolio
Avoro Capital Advisors LLC New York, NY

11.1M
Shares

$368 Million
4.82% of portfolio
Vanguard Group Inc Valley Forge, PA

9.82M
Shares

$325 Million
0.01% of portfolio
Black Rock Inc. New York, NY

5.8M
Shares

$192 Million
0.01% of portfolio

View Full List

About Apellis Pharmaceuticals, Inc.

Ticker APLS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 109,865,000
Market Cap $3.64B
Description
Apellis Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of therapeutic compounds through the inhibition of the complement system for autoimmune and inflammatory diseases. The company's lead product candidate is pegcetacoplan that is in Phase III clinical trials for...

More about APLS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Caption Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Caption Management, LLC with notifications on news.

Account